← FDA DRUG APPROVALS

FDA ANDA · ANDA204060

FOSAMPRENAVIR CALCIUM

Sponsor: MYLAN

APPLICATION
ANDA204060
TYPE
ANDA
ORIGINAL APPROVAL
2016-04-15
LATEST ACTION
2021-03-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FOSAMPRENAVIR CALCIUMPrescription
FOSAMPRENAVIR CALCIUM EQ 700MG BASE · TABLET · ORAL

Approval history

2021-03-19Labeling · Supplement 3 · standardAP
2021-03-19Labeling · Supplement 2 · standardAP
2016-04-15UNKNOWN · Original — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →